The long-term objective of this research is to characterize the molecular mechanisms involved in the regulation of cellular proliferation and differentiation in erythropoiesis. An established hematopoietic cell line, B6SUt, will be employed to test the hypothesis that the activation of phospholipases A2 and C through a pertussis-sensitive G protein is essential for the signal transduction events in erythropoiesis.
Specific Aim #1 will address the question of whether or not diacylglycerol accumulation in response to erythropoietin occurs in a timedependent manner as well as the source(s) of diacylglycerol in these cells. Since it is expected that phospholipase activation will accompany growth factor stimulation, the goal of Specific Aim #2 is to determine the involvement of guanyl nucleotide regulatory proteins (G proteins) in the mechanism of action of erythropoietin. If, as anticipated, G protein function is necessary for subsequent signal transduction events in erythropoiesis, specific G proteins involved will be determined by means of Western blotting experiments with specific antibodies to G proteins and by means of Northern and slot blotting (messenger RNA).
Specific Aim #3 will test the hypothesis that internalization of receptors for erythropoietin and the growth factor/hormone itself is essential for the proliferation of B6SUT cells in response to erythropoietin. Transcription of the protooncogenes,c-fos, c-jun, and c-myc which is associated with the proliferative response will be determined in nuclei exposed to erythropoietin. Erythropoietin, its receptor and specific isoforms of protein kinase C will be localized by means of immunocytochemical methods and electron microscopy. Alterations of the signal sequence for erythropoietin gene will be carried out to determine whether or not erythropoietin must be in the nucleus in order for proliferation to occur. In addition to their inherent biological relevance the molecular mechanisms elucidated will have long-range implications for our understanding of alterations in signal transduction events which result in the loss of differentiation and unregulated proliferation of cancer cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK040501-03
Application #
2141358
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1992-09-30
Project End
1996-09-29
Budget Start
1994-09-30
Budget End
1996-09-29
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Tulane University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Ohigashi, T; Mallia, C S; McGary, E et al. (1999) Protein kinase C alpha protein expression is necessary for sustained erythropoietin production in human hepatocellular carcinoma (Hep3B) cells exposed to hypoxia. Biochim Biophys Acta 1450:109-18
Scandurro, A B; Beckman, B S (1998) Common proteins bind mRNAs encoding erythropoietin, tyrosine hydroxylase, and vascular endothelial growth factor. Biochem Biophys Res Commun 246:436-40
Mallia, C M; Smith, M; Clejan, S et al. (1997) Erythropoietin stimulates nuclear localization of diacylglycerol and protein kinase C beta II in B6SUt.EP cells. J Lipid Mediat Cell Signal 17:135-50
McGary, E C; Rondon, I J; Beckman, B S (1997) Post-transcriptional regulation of erythropoietin mRNA stability by erythropoietin mRNA-binding protein. J Biol Chem 272:8628-34
Scandurro, A B; Rondon, I J; Wilson, R B et al. (1997) Interaction of erythropoietin RNA binding protein with erythropoietin RNA requires an association with heat shock protein 70. Kidney Int 51:579-84
Beckman, B S; Mallia, C; Clejan, S (1996) Molecular species of phospholipids in a murine stem-cell line responsive to erythropoietin. Biochem J 314 ( Pt 3):861-7
Clejan, S; Mallia, C; Vinson, D et al. (1996) Erythropoietin stimulates G-protein-coupled phospholipase D in haematopoietic target cells. Biochem J 314 ( Pt 3):853-60
Patterson, K K; Beckman, B S; Klotz, D M et al. (1996) Dexniguldipine hydrochloride, a protein-kinase-C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels, and nuclear protein phosphorylation in Friend erythroleukemia cells. J Cancer Res Clin Oncol 122:465-75
Mason-Garcia, M; Harlan, R E; Mallia, C et al. (1995) Interleukin-3 or erythropoietin induced nuclear localization of protein kinase C beta isoforms in hematopoietic target cells. Cell Prolif 28:145-55
Mallia, C M; Jeter Jr, J R; Fields, A P et al. (1995) Protein kinase C beta from Friend erythroleukemia cells is associated with chromatin and DNA. Mol Cell Biochem 151:107-11

Showing the most recent 10 out of 12 publications